Our results support our earlier observation in human volunteers immunised with the same vaccine prime-boost regimen and challenged with malaria, where single-positive CD107a CD8+ T cells were significantly associated with efficacy and long term protection12. The gene discussed is LAMP1; the disease is malaria.